Roger Adsett
Chief Operating Officer
Common Stock
- Value context
- $1.12M
- Reported price
- $13.67 / share
INSMED Inc
Last 30 daysNo qualifying insider buying. Sales: $3.1M by 1 insider.
Showing the first 6 of 20 trades on this page.
Chief Operating Officer
Common Stock
Chief Operating Officer
Common Stock
Chief Operating Officer
Common Stock
Chief Operating Officer
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Operating Officer
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Operating Officer
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Medical Officer
Common Stock
Chief Medical Officer
Common Stock
Chief Medical Officer
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Medical Officer
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chair and CEO
Common Stock
Chair and CEO
Common Stock
Chair and CEO
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chair and CEO
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chair and CEO
Common Stock
Chair and CEO
Common Stock
Chair and CEO
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chair and CEO
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Medical Officer
Common Stock
Chief Medical Officer
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Chief Operating Officer | Common StockOption exercise or conversion | 82,280$13.67 / share | $1.12M | Aug 10Filed Aug 12 · 2d later | SEC filing |
| Chief Operating Officer | Common StockOption exercise or conversion | 76,600$17.16 / share | $1.31M | Aug 10Filed Aug 12 · 2d later | SEC filing |
| Chief Operating Officer | Common StockOption exercise or conversion | 80,970$30.46 / share | $2.47M | Aug 10Filed Aug 12 · 2d later | SEC filing |
| Chief Operating Officer | Stock Option (right to buy)Option exercise or conversion | Derivative units82,280$13.67 exercise / conversion price | Not a separate purchase | Aug 10Filed Aug 12 · 2d later | SEC filing |
| Chief Operating Officer | Stock Option (right to buy)Option exercise or conversion | Derivative units76,600$17.16 exercise / conversion price | Not a separate purchase | Aug 10Filed Aug 12 · 2d later | SEC filing |
| Chief Operating Officer | Stock Option (right to buy)Option exercise or conversion | Derivative units80,970$30.46 exercise / conversion price | Not a separate purchase | Aug 10Filed Aug 12 · 2d later | SEC filing |
| Chief Medical Officer | Common StockOption exercise or conversion10b5-1 | 18,278$18.95 / share | $346.37K | Aug 6Filed Aug 7 · 1d later | SEC filing |
| Chief Medical Officer | Common StockOption exercise or conversion10b5-1 | 8,895$25.83 / share | $229.76K | Aug 6Filed Aug 7 · 1d later | SEC filing |
| Chief Medical Officer | Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units18,278$18.95 exercise / conversion price | Not a separate purchase | Aug 6Filed Aug 7 · 1d later | SEC filing |
| Chief Medical Officer | Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units8,895$25.83 exercise / conversion price | Not a separate purchase | Aug 6Filed Aug 7 · 1d later | SEC filing |
| Chair and CEO | Common StockOption exercise or conversion10b5-1 | 6,260$30.46 / share | $190.68K | Jul 23Filed Jul 24 · 1d later | SEC filing |
| Chair and CEO | Common StockOption exercise or conversion10b5-1 | 4,440$17.16 / share | $76.19K | Jul 23Filed Jul 24 · 1d later | SEC filing |
| Chair and CEO | Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units6,260$30.46 exercise / conversion price | Not a separate purchase | Jul 23Filed Jul 24 · 1d later | SEC filing |
| Chair and CEO | Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units4,440$17.16 exercise / conversion price | Not a separate purchase | Jul 23Filed Jul 24 · 1d later | SEC filing |
| Chair and CEO | Common StockOption exercise or conversion10b5-1 | 6,259$30.46 / share | $190.65K | Jul 9Filed Jul 10 · 1d later | SEC filing |
| Chair and CEO | Common StockOption exercise or conversion10b5-1 | 4,440$17.16 / share | $76.19K | Jul 9Filed Jul 10 · 1d later | SEC filing |
| Chair and CEO | Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units6,259$30.46 exercise / conversion price | Not a separate purchase | Jul 9Filed Jul 10 · 1d later | SEC filing |
| Chair and CEO | Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units4,440$17.16 exercise / conversion price | Not a separate purchase | Jul 9Filed Jul 10 · 1d later | SEC filing |
| Chief Medical Officer | Common StockOption exercise or conversion10b5-1 | 7,945$29.13 / share | $231.44K | Jul 6Filed Jul 8 · 2d later | SEC filing |
| Chief Medical Officer | Common StockOption exercise or conversion10b5-1 | 4,357$19.74 / share | $86.01K | Jul 6Filed Jul 8 · 2d later | SEC filing |
Showing the latest 20 of 58 trades. Show all 58 trades
Insmed Incorporated - Common Stock (INSM) · Stock
The filing reports a partial sale for a joint account.
Josh GottheimerReporting House memberInsmed Incorporated - Common Stock (INSM) · Stock
The filing reports a sale for the member.
Gilbert CisnerosReporting House memberInsmed Incorporated - Common Stock (INSM) · Stock
The filing reports a partial sale for the member.
Gilbert CisnerosReporting House memberNo eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.